网站大量收购独家精品文档,联系QQ:2885784924

MCI186 to reduce A140 PC12 cells induced phosphorylation of tau.doc

MCI186 to reduce A140 PC12 cells induced phosphorylation of tau.doc

  1. 1、本文档共14页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
MCI186 to reduce A140 PC12 cells induced phosphorylation of tau

 PAGE \* MERGEFORMAT 14 MCI186 to reduce A140 PC12 cells induced phosphorylation of tau [Abstract] Objective of edaravone (MCI 186) of the amyloid protein (A1 40) induced tau protein phosphorylation in PC12 cells and its mechanism of protection. Methods such as Western blot detection of Ser396, Ser199/202, Tau 5 and GSK 3, GSK 3Ser9 phosphorylation observed MCI 186 A25 35 induced injury in PC12 cells. The results of model group tau protein in Ser396, Ser199/202 phosphorylation sites and total tau protein levels in A1 40 role began to increase after 3 h, while the expression of GSK 3 increased the expression of phosphorylated GSK 3Ser9 reduction, MCI 186 protection group tau protein in the Ser396, Ser199/202 phosphorylation sites and total tau protein levels were significantly lower than A model group (P lt;0.05), GSK 3 expression is reduced, the expression of phosphorylated GSK 3Ser9 increased (P lt;0.05). Conclusions A1 40 PC12 cell injury induced by the process, there has been excessive tau protein phosphorylation, can Ser396, Ser199/202 sites and Tau 5 protein concentration. activate GSK 3 is to produce tau hyperphosphorylation of the main ways. MCI 186 can inhibit the activity of GSK 3, thereby reducing the A1 40-induced tau hyperphosphorylation, to achieve the purpose of protecting nerve cells. [Keywords:] edaravone; Alzheimer’s disease; glycogen synthase kinase 3; tau protein phosphorylation AD is a common neurodegenerative disease, in the pathogenesis of many more scholars tend to change the core of tau hyperphosphorylation. Current clinical drugs used to treat AD are only mild to moderate improvement some patients with symptoms, not alleviate the pathological changes in the brain to stop the progress of the disease, and hyperphosphorylation of tau protein did not reverse the effect. edaravone (MCI 186) is a free radical scavenger, can specifically scavenge hydroxyl radical (OH), secondary to inhibition of oxidative stress and apoptosis play a

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档